title: The Nociceptin Receptor as an Emerging Molecular Target for Cocaine Addiction.
abstract: Cocaine addiction is a global public health and socioeconomic issue that requires pharmacological and cognitive therapies. Currently there are no FDA-approved medications to treat cocaine addiction. However, in preclinical studies, interventions ranging from herbal medicine to deep-brain stimulation have shown promise for the therapy of cocaine addiction. Recent developments in molecular biology, pharmacology, and medicinal chemistry have enabled scientists to identify novel molecular targets along the pathways involved in drug addiction. In 1994, a receptor that showed a great deal of homology to the traditional opioid receptors was characterized. However, endogenous and exogenous opioids failed to bind to this receptor, which led scientists to name it opioid receptor-like receptor, now referred to as the nociceptin receptor. The endogenous ligand of NOPr was identified a year later and named orphanin FQ/nociceptin. Nociceptin and NOPr are widely distributed throughout the CNS and are involved in many physiological responses, such as food intake, nociceptive processing, neurotransmitter release, etc. Furthermore, exogenous nociceptin has been shown to regulate the activity of mesolimbic dopaminergic neurons, glutamate, and opioid systems, and the stress circuit. Importantly, exogenous nociceptin has been shown to reduce the rewarding and addictive actions of a number of drugs of abuse, such as psychostimulants, alcohol, and opioids. This paper reviews the existing literature on the role of endogenous nociceptin in the rewarding and addictive actions of cocaine. The effect of exogenous nociceptin on these processes is also reviewed. Furthermore, the effects of novel small-molecule NOPr ligands on these actions of cocaine are discussed. Overall, a review of the literature suggests that NOPr could be an emerging target for cocaine addiction pharmacotherapy.
authors.affiliation: Department of Pharmaceutical Sciences, College of Pharmacy, Western University of Health Sciences, Pomona, California, USA. Electronic address: klutfy@westernu.edu.
authors.forename: Kabirullah
authors.initials: K
authors.lastname: Lutfy
authors.affiliation: Astraea Therapeutics, LLC, Mountain View, California, USA.
authors.forename: Nurulain T
authors.initials: NT
authors.lastname: Zaveri
mesh_terms: D019970:Cocaine-Related Disorders / Q000503:physiopathology*; D006801:Humans; D011957:Receptors, Opioid / Q000502:physiology*; D000094942:Nociceptin Receptor
chemical_list: D011957:Receptors, Opioid; D000094942:Nociceptin Receptor; C000722283:OPRL1 protein, human
keywords: anxiety; cocaine addiction; nociceptin; nociceptin receptor; opioid receptor-like receptor; orphanin FQ; reinforcement; reward; stress
references.citation: J Pharmacol Exp Ther. 2003 Jan;304(1):310-8
references.pmid: 12490606
references.citation: Brain Res. 1989 Sep 11;497(1):195-8
references.pmid: 2790454
references.citation: Nat Neurosci. 2014 Jan;17 (1):73-80
references.pmid: 24270186
references.citation: Addict Biol. 2013 Mar;18(2):307-24
references.pmid: 23311632
references.citation: Biol Psychiatry. 2010 Jan 1;67(1):36-43
references.pmid: 19765687
references.citation: J Neurosci. 2006 Jul 19;26(29):7723-9
references.pmid: 16855100
references.citation: J Neurochem. 2004 Apr;89(1):257-63
references.pmid: 15030410
references.citation: Neuroscience. 2007 Jun 15;147(1):106-16
references.pmid: 17499930
references.citation: FEBS Lett. 1994 Mar 14;341(1):33-8
references.pmid: 8137918
references.citation: J Comp Neurol. 1999 Apr 19;406(4):503-47
references.pmid: 10205026
references.citation: Eur J Pharmacol. 1995 Jun 23;280(1):55-61
references.pmid: 7498254
references.citation: Psychopharmacology (Berl). 1987;91(1):14-9
references.pmid: 2950541
references.citation: Behav Brain Res. 1999 Mar;99(2):169-79
references.pmid: 10512583
references.citation: Biochem J. 1982 Mar 15;202(3):561-71
references.pmid: 7046734
references.citation: J Neurosci. 2006 Mar 29;26(13):3584-8
references.pmid: 16571766
references.citation: Proc Natl Acad Sci U S A. 2005 Dec 27;102(52):19186-91
references.pmid: 16380431
references.citation: Neuropsychopharmacology. 2005 May;30(5):1006-18
references.pmid: 15785780
references.citation: FEBS Lett. 1997 Jul 28;412(2):290-4
references.pmid: 9256237
references.citation: Addict Biol. 2014 Jul;19(4):575-86
references.pmid: 23240906
references.citation: Neuropeptides. 2014 Aug;48(4):189-97
references.pmid: 24894718
references.citation: Neurochem Int. 2009 May-Jun;54(5-6):378-84
references.pmid: 19418633
references.citation: Can J Physiol Pharmacol. 1998 Mar;76(3):252-8
references.pmid: 9673788
references.citation: Eur J Pharmacol. 1992 Aug 25;219(2):345-6
references.pmid: 1425962
references.citation: Behav Neurosci. 1989 Dec;103(6):1327-34
references.pmid: 2558677
references.citation: Annu Rev Psychol. 2008;59:29-53
references.pmid: 18154498
references.citation: Neuroscience. 1996 Nov;75(1):1-4
references.pmid: 8923516
references.citation: Pharmacol Ther. 2006 Sep;111(3):855-76
references.pmid: 16545872
references.citation: Brain Res. 1991 Sep 13;559(1):29-36
references.pmid: 1782559
references.citation: Br J Pharmacol. 1996 Apr;117(8):1609-11
references.pmid: 8732266
references.citation: Brain Res. 1993 Jul 9;616(1-2):335-8
references.pmid: 8395306
references.citation: Psychopharmacology (Berl). 2000 Dec;153(1):31-43
references.pmid: 11255927
references.citation: Neuropsychopharmacology. 2013 Nov;38(12):2508-14
references.pmid: 23800967
references.citation: J Neurosci. 2003 Nov 12;23 (32):10331-7
references.pmid: 14614092
references.citation: Behav Brain Res. 1999 Aug;103(1):85-93
references.pmid: 10475168
references.citation: Neuroendocrinology. 1998 Feb;67(2):73-82
references.pmid: 9508037
references.citation: Neuropsychopharmacology. 2008 Oct;33(11):2676-87
references.pmid: 18185499
references.citation: Psychopharmacology (Berl). 1994 Jun;115(1-2):121-7
references.pmid: 7862883
references.citation: Hippocampus. 1997;7(1):88-94
references.pmid: 9138672
references.citation: Mol Psychiatry. 2003 Aug;8(8):752-65
references.pmid: 12888804
references.citation: Am J Geriatr Psychiatry. 1997 Fall;5(4):324-32
references.pmid: 9363289
references.citation: Eur J Pharmacol. 1997 Mar 5;321(3):265-71
references.pmid: 9085036
references.citation: Science. 1987 Sep 4;237(4819):1219-23
references.pmid: 2820058
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2014 Mar 3;49:36-46
references.pmid: 24184686
references.citation: Int J Addict. 1988 Apr;23(4):351-78
references.pmid: 3384507
references.citation: J Pharmacol Exp Ther. 1988 Mar;244(3):1067-80
references.pmid: 2855239
references.citation: FEBS Lett. 1994 Jun 27;347(2-3):284-8
references.pmid: 8034019
references.citation: Am J Psychiatry. 1999 Aug;156(8):1223-9
references.pmid: 10450264
references.citation: Psychopharmacology (Berl). 2002 May;161(3):222-32
references.pmid: 12021825
references.citation: Brain Res. 2013 Jul 3;1520:51-60
references.pmid: 23669068
references.citation: J Neurosci. 2012 Jan 25;32(4):1488-95
references.pmid: 22279233
references.citation: Neuropsychopharmacology. 2006 Apr;31(4):787-94
references.pmid: 16123754
references.citation: FEBS Lett. 1994 Jun 27;347(2-3):279-83
references.pmid: 8034018
references.citation: Eur J Med Chem. 2000 Sep;35(9):839-51
references.pmid: 11006485
references.citation: Psychopharmacology (Berl). 2008 Apr;197(3):443-8
references.pmid: 18176854
references.citation: CNS Neurol Disord Drug Targets. 2015;14(6):738-44
references.pmid: 26022263
references.citation: Neuropsychopharmacology. 2014 Oct;39(11):2601-10
references.pmid: 24863033
references.citation: Psychopharmacology (Berl). 2004 Mar;172(2):129-36
references.pmid: 14624329
references.citation: Proc Natl Acad Sci U S A. 2009 Nov 10;106(45):19168-73
references.pmid: 19864633
references.citation: Psychopharmacology (Berl). 1995 May;119(1):92-8
references.pmid: 7675956
references.citation: J Pharmacol Exp Ther. 2001 May;297(2):688-95
references.pmid: 11303059
references.citation: Neurosci Lett. 2002 Nov 8;332(3):159-62
references.pmid: 12399005
references.citation: J Neurosci. 2008 Jan 9;28(2):407-14
references.pmid: 18184783
references.citation: Neuropsychopharmacology. 2004 Jan;29(1):59-71
references.pmid: 14532912
references.citation: J Pharmacol Exp Ther. 1995 May;273(2):808-15
references.pmid: 7752084
references.citation: Brain Res. 2000 Sep 1;875(1-2):44-50
references.pmid: 10967297
references.citation: Nature. 2000 Jan 6;403(6765):41-5
references.pmid: 10638745
references.citation: Neuroscientist. 2003 Apr;9(2):158-68
references.pmid: 12708619
references.citation: Pharmacol Ther. 2013 Oct;140(1):10-25
references.pmid: 23711793
references.citation: Physiol Behav. 2004 Aug;82(1):63-8
references.pmid: 15234592
references.citation: J Neurochem. 1999 Jul;73(1):179-86
references.pmid: 10386969
references.citation: Life Sci. 1997;60(18):PL-257-64
references.pmid: 9126886
references.citation: Psychopharmacology (Berl). 2007 Apr;191(3):391-431
references.pmid: 17072591
references.citation: Life Sci. 1989;45(7):599-606
references.pmid: 2671566
references.citation: Eur J Pharmacol. 1976 Jan;35(1):45-58
references.pmid: 3421
references.citation: Semin Cell Dev Biol. 2009 Jun;20(4):387-94
references.pmid: 19560043
references.citation: Eur J Pharmacol. 2012 Jul 5;686(1-3):50-4
references.pmid: 22575525
references.citation: Child Abuse Negl. 1997 Jun;21(6):529-39
references.pmid: 9192142
references.citation: Neuropharmacology. 2008 Aug;55(2):198-203
references.pmid: 18572206
references.citation: J Neuroendocrinol. 2003 Jan;15(1):69-74
references.pmid: 12535171
references.citation: Neuroscience. 2004;127(2):497-503
references.pmid: 15262338
references.citation: Nature. 1995 Oct 12;377(6549):532-5
references.pmid: 7566152
references.citation: Brain Res Brain Res Rev. 1991 Sep-Dec;16(3):223-44
references.pmid: 1665095
references.citation: J Neurosci. 2013 May 29;33(22):9319-27
references.pmid: 23719800
references.citation: Eur J Pharmacol. 2007 Aug 13;569(1-2):84-9
references.pmid: 17568579
references.citation: Brain Res. 1995 Nov 6;698(1-2):46-52
references.pmid: 8581502
references.citation: Nature. 1996 Feb 15;379(6566):606-12
references.pmid: 8628395
references.citation: Neuroscience. 2006 Oct 13;142(2):481-91
references.pmid: 16893609
references.citation: Bioessays. 2010 Sep;32(9):748-55
references.pmid: 20730946
references.citation: Neuron. 2005 Oct 20;48(2):303-14
references.pmid: 16242410
references.citation: Addiction. 2000 Aug;95 Suppl 2:S91-117
references.pmid: 11002906
references.citation: Am J Psychiatry. 1998 Jun;155(6):726-32
references.pmid: 9619143
references.citation: Psychopharmacology (Berl). 2009 Jun;204(3):457-63
references.pmid: 19199096
references.citation: Behav Pharmacol. 1993;4(4):315-334
references.pmid: 11224200
references.citation: J Neuropsychiatry Clin Neurosci. 1997 Summer;9(3):482-97
references.pmid: 9276849
references.citation: Brain Res Mol Brain Res. 2005 Jun 13;137(1-2):258-62
references.pmid: 15950784
references.citation: Eur J Pharmacol. 2000 Sep 15;404(1-2):153-9
references.pmid: 10980274
references.citation: J Neurosci. 2001 Dec 1;21(23):RC184
references.pmid: 11717387
references.citation: Drug Alcohol Depend. 1998 Jun-Jul;51(1-2):23-47
references.pmid: 9716928
references.citation: Eur J Pharmacol. 2013 May 5;707(1-3):41-5
references.pmid: 23524092
references.citation: Brain Res Brain Res Rev. 2000 Aug;33(1):13-33
references.pmid: 10967352
references.citation: Ann N Y Acad Sci. 1999 Jun 29;877:732-6
references.pmid: 10415694
references.citation: Pharmacol Biochem Behav. 1999 Jun;63(2):271-7
references.pmid: 10371656
references.citation: Br J Pharmacol. 2008 May;154(2):327-42
references.pmid: 18345022
references.citation: Mol Pharmacol. 1996 Sep;50(3):447-50
references.pmid: 8794880
references.citation: Eur J Pharmacol. 1997 Oct 8;336(2-3):233-42
references.pmid: 9384238
references.citation: J Neurosci. 2008 Feb 27;28(9):2190-8
references.pmid: 18305252
references.citation: Science. 1995 Nov 3;270(5237):792-4
references.pmid: 7481766
references.citation: NIDA Res Monogr. 1988;88:14-22
references.pmid: 3145447
references.citation: Neurosci Lett. 1987 Aug 31;79(3):315-20
references.pmid: 2958724
references.citation: FEBS Lett. 1994 Apr 18;343(1):42-6
references.pmid: 8163014
references.citation: Brain Res. 1975 Sep 5;94(3):507-22
references.pmid: 1171714
references.citation: Front Neuroendocrinol. 2014 Apr;35(2):234-44
references.pmid: 24456850
references.citation: Neuropsychopharmacology. 2009 Jul;34(8):1946-57
references.pmid: 19279569
references.citation: Neuroscience. 2004;127(4):929-40
references.pmid: 15312905
references.citation: Nat Rev Neurosci. 2001 Oct;2(10):695-703
references.pmid: 11584307
references.citation: Nature. 1995 Oct 12;377(6549):476
references.pmid: 7566139
references.citation: Behav Pharmacol. 2002 May;13(3):229-35
references.pmid: 12122313
references.citation: Mol Interv. 2002 Jun;2(3):146-57
references.pmid: 14993375
references.citation: Neuropsychopharmacology. 2010 Jan;35(1):217-38
references.pmid: 19710631
references.citation: Biol Psychiatry. 2010 Aug 1;68(3):223-30
references.pmid: 20359694
references.citation: Proc Natl Acad Sci U S A. 2000 Apr 25;97(9):4938-43
references.pmid: 10758169
references.citation: J Pharmacol Exp Ther. 2000 Aug;294(2):680-7
references.pmid: 10900248
references.citation: Nature. 1998 Aug 6;394(6693):577-81
references.pmid: 9707118
references.citation: Neuroscience. 2000;96(4):651-6
references.pmid: 10727783
references.citation: Nature. 2001 Feb 15;409(6822):834-5
references.pmid: 11237002
references.citation: Prog Brain Res. 1993;99:209-26
references.pmid: 8108549
references.citation: Drug Discov Today Dis Models. 2008 Winter;5(4):207-215
references.pmid: 20054425
references.citation: J Neurochem. 2008 Oct;107(2):544-56
references.pmid: 18717817
references.citation: J Neurophysiol. 1998 Sep;80(3):1277-84
references.pmid: 9744938
references.citation: Am J Psychiatry. 1999 Jan;156(1):11-8
references.pmid: 9892292
references.citation: Eur J Pharmacol. 2010 Oct 25;645(1-3):119-26
references.pmid: 20674566
references.citation: Neuron. 2007 Nov 8;56(3):517-29
references.pmid: 17988634
references.citation: Science. 1997 Oct 3;278(5335):52-8
references.pmid: 9311926
references.citation: Neuroreport. 2001 May 8;12 (6):1145-9
references.pmid: 11338181
references.citation: Am J Psychiatry. 2007 Aug;164(8):1149-59
references.pmid: 17671276
references.citation: Brain Res. 1998 Feb 9;783(2):236-40
references.pmid: 9507149
references.citation: Brain Res. 2005 Dec 7;1064(1-2):75-82
references.pmid: 16277980
references.citation: Psychopharmacology (Berl). 2001 Feb;154(1):1-7
references.pmid: 11291998
references.citation: J Neurochem. 2003 Mar;84(5):930-8
references.pmid: 12603818
references.citation: J Neurosci. 2003 Jul 2;23 (13):5674-83
references.pmid: 12843270
references.citation: Eur J Pharmacol. 1996 Mar 18;298(3):207-16
references.pmid: 8846818
references.citation: Pol J Pharmacol. 2002 Jul-Aug;54(4):367-72
references.pmid: 12523490
references.citation: Psychopharmacology (Berl). 2000 Mar;149(1):24-33
references.pmid: 10789879
references.citation: Neuropeptides. 2007 Dec;41(6):399-410
references.pmid: 17980908
references.citation: J Biomed Sci. 1998 Sep-Oct;5(5):309-20
references.pmid: 9758905
references.citation: Psychopharmacology (Berl). 2002 May;161(2):113-9
references.pmid: 11981590
references.citation: Learn Mem. 2006 Mar-Apr;13(2):161-7
references.pmid: 16585791
references.citation: J Neurosci. 1996 Nov 1;16(21):6657-64
references.pmid: 8824306
references.citation: Eur J Pharmacol. 1990 Nov 6;190(1-2):177-84
references.pmid: 1981749
references.citation: Neuron. 2015 May 6;86(3):646-64
references.pmid: 25950633
references.citation: Cell. 2004 Jun 11;117(6):721-33
references.pmid: 15186774
references.citation: J Comp Neurol. 2002 Mar 18;444(4):358-68
references.pmid: 11891648
references.citation: Brain Res. 2003 Jun 6;974(1-2):249-53
references.pmid: 12742644
references.citation: Peptides. 2007 Jun;28(6):1229-39
references.pmid: 17499882
references.citation: Brain Res. 1992 Dec 4;597(2):304-9
references.pmid: 1473001
references.citation: Neuropsychopharmacology. 2008 Jan;33(1):166-80
references.pmid: 17805308
references.citation: Neuropharmacology. 2006 Sep;51(3):487-96
references.pmid: 16781738
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 1988;12(2-3):233-9
references.pmid: 3387585
references.citation: Neuropharmacology. 2014 Jan;76 Pt B:287-300
references.pmid: 23727437
references.citation: Neuropharmacology. 2009;56 Suppl 1:169-73
references.pmid: 18675832
references.citation: J Pharmacol Exp Ther. 1996 Feb;276(2):545-54
references.pmid: 8632320
references.citation: Neuroscience. 1996 Nov;75(2):333-7
references.pmid: 8930999
references.citation: J Neurosci. 1990 Jan;10(1):303-10
references.pmid: 2299396
references.citation: Brain Res. 1999 Jun 19;832(1-2):168-70
references.pmid: 10375664
references.citation: Nat Neurosci. 2003 Jun;6(6):587-92
references.pmid: 12740581
references.citation: Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14854-8
references.pmid: 9405703
references.citation: J Clin Psychol. 1971 Oct;27(4):455-6
references.pmid: 5115648
references.citation: Nat Rev Neurosci. 2004 Jun;5(6):483-94
references.pmid: 15152198
references.citation: Eur J Neurosci. 2006 Jan;23 (1):229-38
references.pmid: 16420432
references.citation: Neuroscience. 2004;125(1):211-20
references.pmid: 15051160
references.citation: Br J Pharmacol. 2004 Sep;143(1):53-62
references.pmid: 15289286
references.citation: Neuropsychopharmacology. 2007 Apr;32(4):902-10
references.pmid: 16880770
references.citation: Proc Natl Acad Sci U S A. 1979 Nov;76(11):5972-6
references.pmid: 392510
references.citation: J Mol Neurosci. 2007;31(2):159-64
references.pmid: 17478889
references.citation: J Neurosci. 2002 May 1;22(9):3306-11
references.pmid: 11978804
references.citation: Exp Clin Psychopharmacol. 2002 May;10(2):84-6; discussion 101-3
references.pmid: 12022802
references.citation: Addict Behav. 1990;15(4):355-65
references.pmid: 2248109
references.citation: Learn Mem. 2007 Jan 03;14 (1-2):29-35
references.pmid: 17202427
references.citation: Neurosci Lett. 1999 Sep 17;272(3):183-6
references.pmid: 10505611
references.citation: Br J Pharmacol. 1996 May;118(2):205-7
references.pmid: 8735615
references.citation: Neuroscience. 2001;102(3):541-53
references.pmid: 11226692
references.citation: Pharmacol Ther. 2007 Nov;116(2):306-21
references.pmid: 17868902
references.citation: Neuropsychopharmacology. 2013 Aug;38(9):1789-97
references.pmid: 23546386
references.citation: Neuropsychopharmacology. 2013 Dec;38(13):2623-31
references.pmid: 23921954
references.citation: Biol Psychiatry. 2002 Nov 15;52(10):976-86
references.pmid: 12437938
references.citation: Pharmacol Rev. 2001 Sep;53(3):381-415
references.pmid: 11546835
references.citation: Neuroreport. 2004 Mar 1;15(3):519-21
references.pmid: 15094515
references.citation: PLoS One. 2009 Dec 31;4(12):e8528
references.pmid: 20052275
references.citation: Psychopharmacology (Berl). 2003 Jul;168(1-2):57-65
references.pmid: 12845418
references.citation: Neurobiol Dis. 2000 Oct;7(5):543-5
references.pmid: 11042073
references.citation: Eur J Neurosci. 2003 May;17(10):2212-8
references.pmid: 12786988
references.citation: Cold Spring Harb Perspect Med. 2013 Mar 01;3(3):a012047
references.pmid: 23359110
references.citation: Behav Neurosci. 2008 Feb;122(1):98-106
references.pmid: 18298253
references.citation: Psychopharmacology (Berl). 2001 Dec;158(4):343-59
references.pmid: 11797055
references.citation: Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7699-704
references.pmid: 9636213
references.citation: J Comp Neurol. 1999 Oct 4;412(4):563-605
references.pmid: 10464356
references.citation: Psychopharmacology (Berl). 2000 Aug;151(2-3):99-120
references.pmid: 10972458
references.citation: Neuropharmacology. 2015 Jun;93:1-6
references.pmid: 25617519
references.citation: J Pharmacol Exp Ther. 2002 Jun;301(3):785-9
references.pmid: 12023504
references.citation: Pharmacol Ther. 2014 Mar;141(3):283-99
references.pmid: 24189487
references.citation: Science. 1996 Mar 15;271(5255):1586-9
references.pmid: 8599115
references.citation: Psychoneuroendocrinology. 2002 Jan-Feb;27(1-2):13-33
references.pmid: 11750768
references.citation: Int J Addict. 1988 Nov;23(11):1101-23
references.pmid: 3235226
references.citation: Neurochem Res. 1996 Nov;21(11):1387-96
references.pmid: 8947929
references.citation: Proc Natl Acad Sci U S A. 1988 Jul;85(14):5274-8
references.pmid: 2899326
references.citation: Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):12040-5
references.pmid: 8876259
references.citation: Neuropharmacology. 2012 Jan;62(1):167-76
references.pmid: 21736885
references.citation: Addict Behav. 2011 Apr;36(4):408-11
references.pmid: 21196083
references.citation: Pharmacol Biochem Behav. 1984 Mar;20(3):451-5
references.pmid: 6324244
references.citation: Annu Rev Neurosci. 2006;29:565-98
references.pmid: 16776597
references.citation: Pain. 2010 Mar;148(3):414-25
references.pmid: 20036056
references.citation: Neuron. 2004 Sep 30;44(1):161-79
references.pmid: 15450168
references.citation: Neuropharmacology. 2012 Aug;63(2):322-9
references.pmid: 22504589
references.citation: Br J Pharmacol. 2002 Aug;136(7):1065-71
references.pmid: 12145107
references.citation: Neuroreport. 2003 Dec 19;14 (18):2383-5
references.pmid: 14663196
references.citation: Eur J Neurosci. 1997 Jan;9(1):194-7
references.pmid: 9042583
references.citation: Neurobiol Learn Mem. 2009 May;91(4):393-401
references.pmid: 19100850
references.citation: Eur J Neurosci. 2002 Mar;15(5):911-22
references.pmid: 11906533
references.citation: Eur J Neurosci. 2004 Mar;19(5):1317-24
references.pmid: 15016089
references.citation: Br J Pharmacol. 2000 Dec;131(7):1379-84
references.pmid: 11090110
references.citation: Brain Res. 1996 Jul 15;727(1-2):225-9
references.pmid: 8842403
references.citation: Neuropharmacology. 2005 Aug;49(2):185-94
references.pmid: 15996567
references.citation: Ann N Y Acad Sci. 1999 Jun 29;877:499-506
references.pmid: 10415667
references.citation: Neuroreport. 1998 Jul 13;9(10 ):2243-7
references.pmid: 9694207
references.citation: Neuropharmacology. 2005 Sep;49(4):439-46
references.pmid: 15919100
references.citation: Br J Pharmacol. 1996 Nov;119(6):1081-3
references.pmid: 8937708
references.citation: Brain Res Brain Res Rev. 1993 Sep-Dec;18(3):247-91
references.pmid: 8401595
references.citation: Neuropharmacology. 2008 Mar;54(3):564-8
references.pmid: 18082848
references.citation: Annu Rev Med. 1998;49:173-84
references.pmid: 9509257
references.citation: Learn Mem. 1999 Sep-Oct;6(5):467-77
references.pmid: 10541467
references.citation: J Pharmacol Exp Ther. 2009 Dec;331(3):954-64
references.pmid: 19773529
references.citation: J Neurosci. 2008 Nov 5;28(45):11673-84
references.pmid: 18987203
references.citation: Neuroreport. 2000 Jun 26;11(9):1939-43
references.pmid: 10884047
references.citation: Life Sci. 2003 Jun 27;73(6):663-78
references.pmid: 12801588
references.citation: Eur J Neurosci. 2000 Aug;12(8):2967-74
references.pmid: 10971637
references.citation: J Neurosci. 2007 Nov 14;27(46):12484-8
references.pmid: 18003826
references.citation: Eur J Pharmacol. 2003 Aug 8;474(2-3):233-9
references.pmid: 12921868
references.citation: Eur J Pharmacol. 2013 Jan 15;699(1-3):200-6
references.pmid: 23219985
references.citation: Eur Neuropsychopharmacol. 2006 Jan;16(1):25-32
references.pmid: 16043329
references.citation: Neuroreport. 2002 Jul 2;13(9):1137-40
references.pmid: 12151756
references.citation: Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5300-5
references.pmid: 11320258
references.citation: Psychopharmacology (Berl). 2002 Nov;164(2):168-76
references.pmid: 12404079
references.citation: J Psychopharmacol. 1998;12(1):49-53
references.pmid: 9584968